Table S2. Summary statistic from linear mixed models testing the change in methylation after DEX for each CpG sites assessed in study 1 (n = 228) including post-hoc analysis for each time point. In bold are sites with significant DEX-induced methylation change. (XLSX 234 kb
Additional file 14: Figure 6. A) Mixture of normal distributions and clusters of CpGs according to t...
Additional file 10: Figure 4: A) Proportion of CpGs, B) unique CpGs, C) SNPs and D) unique SNPs in m...
High confidence differentially methylated sites according to Dexamethasone assay subgroups. Differen...
Table S6. Summary statistic from the linear mixed models testing the change in methylation after DEX...
Table S3. Summary statistic from linear mixed models testing the change in methylation after DEX inc...
Table S5. Results from stepwise regression analyses comparing the LMM models without covariate, with...
Figure S3. CpG sites with significant genotype-dependent dynamic methylation differences in both stu...
Table S4. Location of HAM-TBS amplicons and primer sequences used to analyze FKBP5 CpGs. (XLSX 15 kb
Figure S2. DEX-induced changes in DNAm are also influenced by factors associated with early life adv...
Figure S4. Replication of dexamethasone (DEX)-induced methylation changes (n = 106 subjects) analyze...
Figure S1. Change in blood cell counts after DEX administration. A) Actual blood cell counts at base...
Background Epigenetic mechanisms may play a major role in the biological embedding of early-life st...
Figure S5. Comparison of chromatin states in FKBP5 across brain, immune/blood, and fibroblasts. A) G...
Supplementary Table 1: Location of differentially methylated CpG sites. Probe locations in relation ...
BackgroundEpigenetic mechanisms may play a major role in the biological embedding of early-life stre...
Additional file 14: Figure 6. A) Mixture of normal distributions and clusters of CpGs according to t...
Additional file 10: Figure 4: A) Proportion of CpGs, B) unique CpGs, C) SNPs and D) unique SNPs in m...
High confidence differentially methylated sites according to Dexamethasone assay subgroups. Differen...
Table S6. Summary statistic from the linear mixed models testing the change in methylation after DEX...
Table S3. Summary statistic from linear mixed models testing the change in methylation after DEX inc...
Table S5. Results from stepwise regression analyses comparing the LMM models without covariate, with...
Figure S3. CpG sites with significant genotype-dependent dynamic methylation differences in both stu...
Table S4. Location of HAM-TBS amplicons and primer sequences used to analyze FKBP5 CpGs. (XLSX 15 kb
Figure S2. DEX-induced changes in DNAm are also influenced by factors associated with early life adv...
Figure S4. Replication of dexamethasone (DEX)-induced methylation changes (n = 106 subjects) analyze...
Figure S1. Change in blood cell counts after DEX administration. A) Actual blood cell counts at base...
Background Epigenetic mechanisms may play a major role in the biological embedding of early-life st...
Figure S5. Comparison of chromatin states in FKBP5 across brain, immune/blood, and fibroblasts. A) G...
Supplementary Table 1: Location of differentially methylated CpG sites. Probe locations in relation ...
BackgroundEpigenetic mechanisms may play a major role in the biological embedding of early-life stre...
Additional file 14: Figure 6. A) Mixture of normal distributions and clusters of CpGs according to t...
Additional file 10: Figure 4: A) Proportion of CpGs, B) unique CpGs, C) SNPs and D) unique SNPs in m...
High confidence differentially methylated sites according to Dexamethasone assay subgroups. Differen...